VSL#3 and remission in active ulcerative colitis: larger studies required

Am J Gastroenterol. 2011 Mar;106(3):547; author reply 547-8. doi: 10.1038/ajg.2010.451.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Azathioprine / therapeutic use
  • Bifidobacterium
  • Colitis, Ulcerative / drug therapy*
  • Diet*
  • Drug Therapy, Combination
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Lactobacillus
  • Mesalamine / therapeutic use
  • Methotrexate / therapeutic use
  • Probiotics / administration & dosage
  • Probiotics / therapeutic use*
  • Randomized Controlled Trials as Topic
  • Remission Induction
  • Reproducibility of Results
  • Severity of Illness Index

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Immunosuppressive Agents
  • Mesalamine
  • Azathioprine
  • Methotrexate